Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Somatic BHD mutations are rare in Japanese renal tumors.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

The treatment was ineffective in humans.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blocking mTORC1 reduces skin tumor growth in mice.

HPV8 E6 gene causes growth of certain skin stem cells.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

A group has developed therapies that show promise for treating cancer and various other conditions.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

High DKK1 levels predict worse survival in head and neck cancer.